A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

NCT06329141 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Vutiglabridin
DRUG: Placebo

Sponsor

Glaceum

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]